TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
Home
Press release
Jun 27, 2022 18:00 JST
Source:
Science and Technology of Advanced Materials
Novel patching material for bone defects
Scientists at Tokyo Medical and Dental University have discovered a new type of bone repairing material that could be used to more precisely fix bone defects.
TSUKUBA, Japan, Jun 27, 2022 - (ACN Newswire) - Ceramics and metals have been used for a while as structural materials to repair bones and joints. In the past, scientists engineered bioinert materials, which do not bond to bones directly; bioactive materials that can bond to bones; and bio-absorbable materials that are categorized in bioactive materials but they are absorbed by the body over time and are replaced by advancing bone tissue.
A new bio-responsive ceramic can be used to repair bone defects
With an enzyme found in blood, different types of salts were converted to hydroxyapatite, a bone mineral
Now, a fourth type of bone repairing materials has been found: a bio-responsive ceramic that interacts with an enzyme found in blood to be absorbed into the body at a precise and predictable rate.
The research was done by Taishi Yokoi, an associate professor at the Institute of Biomaterials and Bioengineering at Tokyo Medical and Dental University, and his colleagues. The study was published in May in Science and Technology of Advanced Materials.
"Extending healthy life expectancy is an important issue for all of us," Yokoi says. "Bone repairing materials aid in the recovery of bone defects and help improve quality of life."
At the heart of this discovery is a biological reaction: an enzyme called alkaline phosphatase (ALP), which is present in human serum and reacts with various phosphate esters to generate bone mineral known as hydroxyapatite.
The scientists mimicked this process using a simulated body fluid that contained the enzyme ALP. They placed four different salts in a simulated body fluid containing or lacking the enzyme ALP. The salts were calcium salts of methyl phosphate (CaMeP), ethyl phosphate (CaEtP), butyl phosphate (CaBuP) and dodecyl phosphate (CaDoP). The phosphate component of each of these salts has an alkyl group at its end - a chain composed of hydrogen and carbon atoms - of differing lengths.
The scientists found that the first three salts were converted to hydroxyapatite, but only in the presence of ALP. Interestingly, the length of the alkyl group on the phosphate ester determined the rate at which this reaction happens. With more research, the scientists think that this could allow greater control of the bone healing process in the body.
"We expect the findings of this study will be applied towards designing and developing novel bone-repairing materials with precisely controlled degradation and resorption rates inside the body," says Yokoi.
Further information
Taishi Yokoi
Tokyo Medical and Dental University
Email:
yokoi.taishi.bcr@tmd.ac.jp
Research paper:
https://www.tandfonline.com/doi/full/10.1080/14686996.2022.2074801
About Science and Technology of Advanced Materials (STAM)
Open access journal STAM publishes outstanding research articles across all aspects of materials science, including functional and structural materials, theoretical analyses, and properties of materials.
https://www.tandfonline.com/STAM
Mikiko Tanifuji
STAM Publishing Director
Email:
TANIFUJI.Mikiko@nims.go.jp
Press release distributed by Asia Research News for Science and Technology of Advanced Materials.
Source: Science and Technology of Advanced Materials
Sectors: Materials & Nanotech, BioTech, Healthcare & Pharm
Copyright ©2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Related Press Release
Graphene quantum dots show promise in targeting Parkinson's-related protein clumping
May 20 2026 17:00 JST
Progress towards potassium-ion batteries
July 08 2025 06:48 JST
New method to blend functions for soft electronics
June 23 2025 00:15 JST
New Database of Materials Accelerates Electronics Innovation
May 05 2025 03:20 JST
High-brilliance radiation quickly finds the best composition for half-metal alloys
January 28 2025 08:00 JST
Machine learning used to optimise polymer production
December 03 2024 23:15 JST
Machine learning can predict the mechanical properties of polymers
October 25 2024 23:00 JST
Dual-action therapy shows promise against aggressive oral cancer
July 30 2024 20:00 JST
A new spin on materials analysis
April 17 2024 22:00 JST
Kirigami hydrogels rise from cellulose film
April 12 2024 18:00 JST
More Press release >>
Latest Press Release
Marketing Authorization Application for In-house Developed Insomnia Drug Lemborexant Accepted for Evaluation by European Medicines Agency (EMA)
Jul 18, 2026 00:24 JST
Hitachi and NVIDIA collaborate to advance HMAX and enable end-to-end autonomous operations through the integrated control of physical AI
Jul 17, 2026 23:35 JST
Toyota's First "BE creation" Spin-Off Begins Operations in Japan
Jul 17, 2026 23:00 JST
MHI Advances AI Infrastructure Commercialization with U.S. Deployment of 10MW-Class Chiller and MCP Development
Jul 17, 2026 22:47 JST
Noetra Launches Full-Scale R&D for Japan-Developed Multimodal Foundation Model
Jul 17, 2026 22:16 JST
Mitsubishi Motors Launches the Xforce HEV in Indonesia
Jul 17, 2026 21:47 JST
Fujitsu to explore physical AI development and implementation across industries with FANUC, Yaskawa Electric, and Kawasaki Heavy Industries integrating NVIDIA technology
Jul 17, 2026 21:05 JST
JCB Celebrates 30 Years of Trust, Honoring 70 Years of Japan-Philippines Friendship
Jul 17, 2026 10:00 JST
TANAKA Commences Operation of "TANAKA H2 Nexus", One of Japan's Largest 500 kW Pure Hydrogen Fuel Cell Power Generation Facilities
Jul 16, 2026 22:00 JST
LEQEMBI(R) Real-World LEADER Study Presented at AAIC(R) 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment
Jul 16, 2026 00:18 JST
FDA Approves LEQEMBI IQLIK(R) (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer's Disease
Jul 15, 2026 23:51 JST
Eisai Presents Latest Findings Showed Etalanetug Reduced Alzheimer's Disease Tau Tangle-Specific Plasma Biomarker MTBR-tau243 at Alzheimer's Association International Conference(R) (AAIC(R)) 2026
Jul 15, 2026 23:21 JST
NEC develops world's first proprietary-AI technology to rapidly generate highly detailed 3D models solely from general-purpose camera footage while automatically removing unnecessary subjects
Jul 15, 2026 22:53 JST
Hitachi Rail achieves EcoVadis platinum medal, ranking among the top 1% of companies worldwide for sustainability performance
Jul 15, 2026 22:35 JST
Anime Tokyo Station Reaches 300,000 Visitors!
Jul 15, 2026 11:00 JST
Fujitsu launches AI-driven modernization service to accelerate legacy system transformation
Jul 14, 2026 19:12 JST
Anime Tokyo Station: TV Anime "BLEACH: THE BLOOD WARFARE - The Calamity" Special Exhibition
Jul 14, 2026 11:00 JST
JCB Signs Memorandum of Understanding with Circle to Explore Collaboration Utilizing Stablecoins
Jul 14, 2026 10:00 JST
Mitsubishi Power Receives Contract to Supply Boilers for Fuel Conversion Work at Existing Thermal Power Plants in Saudi Arabia
Jul 14, 2026 00:58 JST
Fujitsu developed an AI Agent to collaborate with store managers for AEON Food Style's strategic store operations
Jul 14, 2026 00:38 JST
More Latest Release >>